動態

• 

  Mary Grace N. Tamio  

  在 October 30 2023 at 07:34 PM 已編輯 public

  Long-term outcomes with rituximab as add-on therapy in severe childhood-onset lupus nephritis
  
  #rituximab #lupusnephritis #journals #articles
  
  More info | ⬇️
  https://social.cn1699.com/livenewss/news/258714

  

  Long-term outcomes with rituximab as add-on therapy in severe childhood-onset lupus nephritis | CN1699 Social

  The social Community for Global Healthcare Elites. Doctors, Medical Professionals & Pharmaceutical professionals. Medical Thesis Abstracts and...
  0 0 0 0 0 0 0

  comment 留言

  thumb_upLike

  share 分享
• 

  Mary Grace N. Tamio   shared news

  在 October 26 2022 at 10:45 PM 已編輯 public

  Simplified regimen of combined low-dose rituximab for autoimmune encephalitis with neuronal surface antibodies
  
  #rituximab #autoimmuneencephalitis #antibodies #journals #articles
  
  More info | ⬇️

  

  Simplified regimen of combined low-dose rituximab for autoimmune encephalitis with neuronal surface antibodies

  Autoimmune encephalitis (AE) with neuronal surface antibodies (NSAbs) presents pathogenesis mediated by B cell-secreting a...
  0 0 0 0 0 0 0

  comment 留言

  thumb_upLike

  share 分享
• 

  Mary Grace N. Tamio   shared news

  在 June 15 2021 at 08:09 PM 已編輯 public

  Rituximab versus Mycophenolate Mofetil in Patients with Pemphigus Vulgaris
  
  #rituximab #mycophenolatemofetil #pemphigusvulgaris #journals #articles #casestudy
  
  For more information | ⬇️
  0 0 0 0 0 0 0

  comment 留言

  thumb_upLike

  share 分享